Insider Transactions in Q2 2021 at Metacrine, Inc. (MTCR)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 20
2021
|
Hubert C Chen Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
3,289
+50.0%
|
$9,867
$3.6 P/Share
|
May 20
2021
|
Preston Klassen Director |
BUY
Open market or private purchase
|
Direct |
20,547
+50.0%
|
$61,641
$3.64 P/Share
|
May 05
2021
|
Trisha Millican Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
759
+1.78%
|
-
|
May 05
2021
|
Catherine Chai Zon Lee EVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
3,846
+50.0%
|
-
|